Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Fellows Forum Case Report: Neuromyelitis Optica

Atul Kapila, MD, Tayseer Haroun, MBBS, & Jayanth Doss, MD  |  Issue: April 2017  |  April 19, 2017

In this case of a neuromyelitis optica spectrum disorder, the patient presented with bilateral vision loss.

In this case of a neuromyelitis optica spectrum disorder, the patient presented with bilateral vision loss.
Lightspring/shutterstock.com

Case Presentation

The patient was a 42-year-old African American female diagnosed with systemic lupus erythematosus (SLE) based on the findings of polyarthritis, malar and discoid rash, fatigue, positive double-stranded DNA (dsDNA) ribonucleoprotein and Smith antibodies, and low serum complement levels. Her SLE had been well controlled on hydroxychloroquine 400 mg daily, oral methotrexate 25 mg weekly and prednisone 10 mg daily.

She felt well until two days prior to her presentation, when she started experiencing neck pain, which was associated with nausea, vomiting and blurred vision in her left eye, which rapidly progressed to bilateral vision loss. She could visualize only shadows of objects less than one foot from her face. She described one episode of fever to 102º Fahrenheit. She denied any additional symptoms, such as numbness, tingling, weakness, slurred speech, new rash, cough, shortness of breath, abdominal pain, diarrhea, constipation, dysuria or change in urine frequency or color.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

She presented to an emergency department where a lumbar puncture was performed, demonstrating an opening pressure of 22 cm. The cerebrospinal fluid (CSF) analysis revealed 233 white blood cells/uL (79% polymorphic neutrophils, 7% lymphocytes), 3 red blood cells/uL, glucose of 34 mg/dL (serum glucose 86 mg/dL) and elevated protein of 96 mg/dL. Gram stain noted rare white blood cells without any organisms. Multiple other studies to rule out infection were ordered. Out of concern for possible meningitis, vancomycin, ceftriaxone, ampicillin, acyclovir and dexamethasone were empirically administered. The patient was transferred to our facility for further care.

On exam, her vital signs, including temperature, were normal. She had chronic discoid skin lesions, but no new or active lesions were seen. The only other abnormality on exam was near total vision loss, for which she displayed a belle indifference. She could visualize only hand motions and blinked to confrontation. Dilated funduscopic examination performed by ophthalmology was normal, without optic nerve edema or pallor. There were no afferent pupillary defects.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The laboratory work-up was notable for a white blood cell count of 3.1×109/L (range 3.2–9.8) with 84% neutrophils, hemo­globin 11.6 g/dL (range 12–15.5), sedimentation rate of 20 mm/hr, C-reactive protein of 1.2 mg/dL (range <0.6), dsDNA 263 IU/mL (range <100, patient’s baseline above 200), C3 of 69 mg/dL (range 86–208, patient’s baseline 75–85), and C4 of 10 mg/dL (range 13–47, patient’s baseline 12–14). Urinalysis was negative for blood or protein.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsOther Rheumatic Conditions Tagged with:case reportcentral nervous systemClinicalDevic's diseaseDiagnosiseyeFellowsFellows Foruminflammatory syndromeneuromyelitis opticaoutcomerheumatologyTreatmentvision

Related Articles
    Cincinart / shutterstock.com

    Case Report: Sjögren’s Syndrome Plus Neuromyelitis Optica Spectrum Disorder

    June 17, 2019

    Sjögren’s syndrome is a chronic multi-system autoimmune disease characterized by inflammation and subsequent destruction of exocrine glands. Sjögren’s syndrome can present with glandular or extra-glandular manifestations. Neuromyelitis optica spectrum disorder (NMOSD) is a rare central nervous system (CNS) autoimmune disease that can present as the initial manifestation in less than 5% of patients with Sjögren’s….

    Diagnostic Criteria Released for Neuromyelitis Optica Spectrum Disorders

    November 16, 2015

    Recent updates to criteria used for diagnosing neuromyelitis optica (NMO) are aimed at helping physicians make the differential diagnosis of this disorder differentiating it from other inflammatory disorders—a diagnosis that can be difficult given the presenting symptoms that can mimic a number of other conditions, such as multiple sclerosis. Published in July 2015, the new…

    Potential Therapeutic Target for SpA

    January 23, 2018

    Innate lymphoid cells (ILCs) in the joints of patients may drive the pathology of spondyloarthritis through the production of granulocyte colony-stimulating factor (GM-CSF). A recent study found that both GM-CSF-producing CD4 T cells and the GM-CSF+ Th17 cells expressed high levels of GPR65—indicating that both GM-CSF and GPR65 may be therapeutic targets for spondyloarthritis…

    Rheumatic Disease Manifestations in the Central Nervous System

    January 19, 2016

    SAN FRANCISCO—Let’s say your radiologist comes to you and says that an angiogram gives a diagnosis of CNS vasculitis on four patients, all with acute onset of headache and stroke: One is a 25-year-old woman who is three months pregnant. Another is a 50-year-old man using excessive doses of nasal decongestants. Another is a 40-year-old…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences